BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34818576)

  • 1. Elucidated tumorigenic role of MAML1 and TWIST1 in gastric cancer is associated with Helicobacter pylori infection.
    Hamidi AA; Forghanifard MM; Gholamin M; Moghbeli M; Memar B; Jangjoo A; Motie MR; Molaei F; Abbaszadegan MR
    Microb Pathog; 2022 Jan; 162():105304. PubMed ID: 34818576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.
    Forghanifard MM; Moaven O; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Moghbeli M; Nejadsattari T; Parivar K; Abbaszadegan MR
    Ann Surg Oncol; 2012 Mar; 19(3):743-9. PubMed ID: 22006371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
    Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
    Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.
    Ardalan Khales S; Ebrahimi E; Jahanzad E; Ardalan Khales S; Forghanifard MM
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e434-e441. PubMed ID: 29333702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation.
    Krzysiek-Maczka G; Targosz A; Szczyrk U; Strzalka M; Brzozowski T; Ptak-Belowska A
    J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 31889044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation.
    Kim HJ; Kim N; Kim HW; Park JH; Shin CM; Lee DH
    Gastric Cancer; 2021 Mar; 24(2):302-313. PubMed ID: 32915372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of long non-coding RNA LINC01389, LINC00365, RP11-138J23.1, and RP11-354K4.2 in gastric cancer and their impacts on EMT.
    Taghehchian N; Farshchian M; Mahmoudian RA; Asoodeh A; Abbaszadegan MR
    Mol Cell Probes; 2022 Dec; 66():101869. PubMed ID: 36208698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
    Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
    Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4).
    Yu H; Zeng J; Liang X; Wang W; Zhou Y; Sun Y; Liu S; Li W; Chen C; Jia J
    PLoS One; 2014; 9(8):e105306. PubMed ID: 25144746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS2 and Twist1 promote invasiveness of Helicobacter pylori-infected gastric cancer cells by inducing Siah2.
    Das L; Kokate SB; Rath S; Rout N; Singh SP; Crowe SE; Mukhopadhyay AK; Bhattacharyya A
    Biochem J; 2016 Jun; 473(11):1629-40. PubMed ID: 27048589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
    Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
    Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin‑binding protein 1A mutation‑positive Helicobacter pylori promotes epithelial‑mesenchymal transition in gastric cancer via the suppression of microRNA‑134.
    Huang L; Wang ZY; Pan DD
    Int J Oncol; 2019 Mar; 54(3):916-928. PubMed ID: 30569124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
    Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
    Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
    Li W; Wang Z; Zha L; Kong D; Liao G; Li H
    Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
    Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
    Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
    Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
    Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.